<DOC>
	<DOCNO>NCT02343003</DOCNO>
	<brief_summary>This study design : - Determine effectiveness ( primarily measure pain relief ) Coolief use create radiofrequency lesion genicular nerve compare pain relief follow corticosteroid injection ; - Confirm safety Coolief use perform radiofrequency lesion genicular nerve subject manage knee pain compare safety corticosteroid injection</brief_summary>
	<brief_title>Nerve Ablation Cooled Radiofrequency Compared Corticosteroid Injection Management Knee Pain</brief_title>
	<detailed_description>This prospective , randomize , multicenter comparison study examine outcome subject knee pain undergoing procedure create radiofrequency lesion genicular nerve Coolief system compare subject receive corticosteroid injection . A total approximately 144 subject enrol study subject undergo either radiofrequency neurotomy corticosteroid injection 1:1 randomization scheme . Follow conduct total 12 month post Coolief procedure primary endpoint complete month 6 . Subjects randomize comparison ( corticosteroid ) group option cross neurotomy group complete 6 month endpoint assessment . They would follow additional 6 month . Pain , overall outcome , quality life , pain medication use , adverse event compare two treatment group order determine success . Primary Effectiveness Endpoint : The proportion subject whose knee pain reduce ≥ 50 % base NRS scale 6 Months . Primary Safety Endpoint : The proportion subject experience adverse event final follow . Secondary Effectiveness Endpoints : - The proportion subject whose knee pain reduce baseline ≥ 50 % base Numeric Rating Scale ( NRS ) 12 month . - Improvement global outcome baseline measure Oxford Knee Score 6 month 12 month . Tertiary Effectiveness Endpoint : Subject satisfaction measure Global Perceived Effect Score 6 month 12 month . Quaternary Effectiveness Endpoint : Reduction pain medication usage baseline measure subject self-reported average daily dosage . In addition , exploratory analyse health economic indicator may perform . Subjects participate study 13 month ( 2 week roll-in period + treatment visit + 12 month follow ) , except subject participate optional crossover group . These crossover subject study 15 month ( 2 week roll-in + treatment + 6 month follow-up crossover + 6 month follow ) . Enrollment anticipate take approximately 6-8 month .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Age ≥ 21 year 2 . Able understand inform consent form provide write informed consent able complete outcome measure 3 . History chronic knee pain longer 6 month unresponsive conservative treatment ( PT , oral analgesic , intraarticular injection steroid and/or viscosupplementation ) 4 . Positive response ( defined decrease numeric pain score least 50 % ) geniculate nerve block index knee 5 . Pain NRS ≥ 6 10 point scale index knee 6 . Radiologic confirmation osteoarthritis ( xray/MRI/CT ) OA grade 2 ( mild ) , 3 ( moderate ) 4 ( severe ) note within 12 month index knee 7 . Oxford Knee Score group Baseline ≤ 35 indicate moderate severe OA index knee 8 . If patient take opioid morphine equivalent medication , dose must consider clinically stable ( defined &lt; 10 % change dosage ≥ 2 month prior screen visit ) . 9 . Analgesics include membrane stabilizer Neurontin antidepressant pain Cymbalta must clinically stable ( define stable dosage ≥ 6 week prior screen visit ) shall change course study without approval investigator . Agree see one pain doctor ( study investigator ) knee pain study period 10 . Index knee pathology consistent generally accept indication total knee arthroplasty . 11 . Willing delay surgical intervention index knee 12 month . 12 . Willingness provide informed consent comply requirement protocol full duration . EXCLUSION CRITERIA 1 . Pseudo arthritis , rheumatoid arthritis systemic inflammatory arthritis condition could cause knee pain . 2 . Previous pending low limb amputation . 3 . Intraarticular steroid , platelet rich plasma ( PRP ) hyaluronic acid injection index knee within 90 day screen visit . 4 . An intraarticular corticosteroid injection indicate appropriate treatment option . 5 . Prior radiofrequency genicular nerve index knee . 6 . Prior partial , resurface , total knee arthroplasty index knee . 7 . Clinically significant ligamentous laxity index knee . 8 . Evidence structural abnormality osteoarthritis knee , hip back materially affect gait function knee underlying cause knee pain . 9 . BMI &gt; 40 . 10 . Extremely thin patient minimal subcutaneous tissue thickness would accommodate lesion 14 mm diameter limit risk skin burn . 11 . Pending active compensation claim , litigation disability remuneration ( secondary gain ) relate knee . 12 . Pregnant intent become pregnant study period . 13 . Chronic pain associate significant psychosocial dysfunction . 14 . Beck 's Depression Index score &gt; 22 ( indicates clinically depressed state ) . 15 . Allergies medication used procedure . 16 . Systemic localized infection needle entry site ( subject may consider inclusion infection resolve ) . 17 . History uncontrolled coagulopathy , ongoing coagulation treatment unexplained uncontrollable bleeding uncorrectable . 18 . Identifiable anatomical variability would materially alter procedure describe protocol . 19 . Within precede 2 year , subject suffer active narcotic addiction , substance alcohol abuse . 20 . Current prescribed opioid medication equivalent great 60 morphine equivalent daily opioid dose . 21 . Uncontrolled immunosuppression ( e.g . AIDS , cancer , diabetes , etc . ) 22 . Subject currently implant pacemaker defibrillator . 23 . Participating another clinical trial/investigation within 30 day prior sign inform consent . 24 . Subject unwilling unable comply follow schedule protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>cool radiofrequency ablation</keyword>
	<keyword>knee pain</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>pain management</keyword>
</DOC>